Call Spread on EXAS on 12/21/2020

Exact Sciences Corporation (EXAS) provides cancer screening and diagnostic test products in the United States and internationally.

The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer.

It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer.

The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

We will be trading a Call Spread on January 15th

Last Trade: $137.05

Tradinf Range: $35.25 - $141.90

Trade Buy 1 January $135.00 Call at $9.75 Sell 1 January $150.00 Call at $3.80 For a net debit of $5.95 Profit/Loss Analysis Breakeven at $140.95 Maximum profit is $905.00 at strike of $150.00 Maximum loss is ($595.00) at strike of $135.00 Closing Summary Sold 1 January $135.00 Call at $16.50 Bought 1 January $150.00 Call at $4.00

Position closed on 1/12/2021 at price of $12.50 with a 110.08% gain in 22 days.

Updates

1/12/2021 10:10:22 AM

closing EXAS call spread

Back to Portfolio